WPD Pharmaceuticals S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-05-23
Share capital
183,425.00 PLN
Activity description

Wpd Pharmaceuticals is focused on developing biological and chemical molecules for targeted therapy aimed at treating brain glioma and other central nervous system cancers. The company is based in Warsaw, Poland.

Registered address
ul. Żwirki I Wigury 101, 02-089 Warszawa, Poland
Phone
Electronic delivery address
AE:PL-30664-56884-UJSTH-21

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 2 financial statements was filed late (for 2024, 9 days late). All were audited by a statutory auditor.

  • 202515/06/2026
  • 202424/07/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 47%
City · Warszawa36,528 / 56,729
Top 64%
Voivodeship · Mazowieckie50,647 / 76,892
Top 66%
Country · Poland200,061 / 297,069
Top 67%

Results vs industry

Revenue
This companyUSD 87.56kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD 30.87kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 12.70kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 1.47mMedianUSD 134.71kAverageUSD 3.04m

Offer

Websites

Authorized Representatives

Mariusz Olejniczak age 52 – President of the Management Board

Manner of representation

The following person or persons are authorized to represent the company and to make declarations on its behalf with respect to the company's property and non-property rights and obligations: in the case of a one-person management board – the President of the Management Board independently; in the case of a multi-member management board – two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy.

Supervisory board

Andrzej Jan Trznadel – Supervisory Board Member
Mariusz Józef Czekała age 68 – Supervisory Board Member
Romuald Harwas age 54 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2024-07-01.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jul 14, 2026Merger registered
Mar 27, 2026Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Vasa Therapeutics sp. z o.o.
Medicofarma Biotech S.A.
Globe Badania Kliniczne sp. z o.o.
Ti-Com sp. z o.o.
Cogniguard sp. z o.o.
Personather sp. z o.o.
Orphinic Scientific S.A.
Biolabic sp. z o.o.
DR Joanna Sanford sp. k.
Nanovelos S.A.

Change history

DateEvent
2026-04-29Share capital increase
2025-08-21Share capital increase
2025-01-23Share capital increase
2024-09-02Share capital increase
2024-07-12Share capital increase

FAQ

Last updated: 2026-10-22